2-Methylpyrimidin-4(3H)-one

Catalog No.: 
ACFBDC157
CAS No.: 
19875-04-8
Molecular Formula: 
C5H6N2O
Molecular Weight: 
110.12
2-Methylpyrimidin-4(3H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$51.00In stockInquiry
10g98%$101.00In stockIn stock
25g98%$251.00In stockIn stock
100g98%$760.00In stockIn stock
500g98%$2949.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Methylpyrimidin-4(3H)-one
IUPAC Name2-methylpyrimidin-4-ol
MDL No.MFCD00234103
Molecular FormulaC5H6N2O
Molecular Weight110.12
SMILESOC1=NC(=NC=C1)C
InChI KeyQWIDYOLZFAQBOB-UHFFFAOYSA-N
Synonym2-Methylpyrimidin-4-ol | 4-Hydroxy-2-methylpyrimidine | 67383-35-1 | 19875-04-8 | 2-methylpyrimidin-4(3H)-one | 2-Methyl-4(3H)-pyrimidinone | 4(1H)-Pyrimidinone, 2-methyl- | 2-methyl-1H-pyrimidin-6-one | 2-methyl-4-pyrimidinol | 4(1H)-Pyrimidinone, 2-methyl- (8CI,9CI) | 4(3H
CAS No.19875-04-8
PubChem CID250451

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACFBDC157 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOMEI240 route compound structure diagram
    ACOMEI2407314-65-0In Stock
  2. Then
  3. ACFBDC157 route product structure diagram
    ACFBDC15719875-04-8In Stock
Inquiry

2. ACFBDC157 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBQPE592 route compound structure diagram
    ACBQPE59217551-52-9In Stock
  2. Then
  3. ACFBDC157 route product structure diagram
    ACFBDC15719875-04-8In Stock
Inquiry

3. ACFBDC157 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFBDC157 route product structure diagram
    ACFBDC15719875-04-8In Stock
Inquiry

Comments (0)